Home › Trial NCT01919866
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells
- Trial IDNCT01919866
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorUniversity Children's Hospital Tuebingen
- Enrollment120
- Start date2004-03
- ConditionsAcute Leukemias · Aplastic Anemia · Childhood Solid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.